Clinical trial
A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease…
NCT00294541 · Icagen, Industry · Terminated
Key facts
| NCT number | NCT00294541 |
|---|---|
| Title | A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy |
| Official title | An Open-Label Extension Study Evaluating the Long-Term Safety of ICA-17043 With or Without Hydroxyurea Therapy in Subjects With Sickle Cell Disease |
| Lead sponsor | Icagen, Industry |
| Collaborators | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease, Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | ICA-17043 |
| Enrollment | 51 |
| Start date | Feb 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Feb 22, 2006 |
| Last update posted | Sep 11, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: